Anti-CD19-CAR-T Cells in Relapsed/Refractory B-cell Tumor Patients.

Conditions: B Cell Malignancies Interventions: Biological: anti-CD19-CAR-T cells Sponsors: Shanghai Tongji Hospital, Tongji University School of Medicine Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials